Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemung Financial (CHMG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Chemung Financial (CHMG) over the last 10 years, with Q3 2025 value amounting to $107.6 million.

  • Chemung Financial's Cash & Equivalents rose 3382.15% to $107.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.6 million, marking a year-over-year increase of 3382.15%. This contributed to the annual value of $47.0 million for FY2024, which is 2764.95% up from last year.
  • Latest data reveals that Chemung Financial reported Cash & Equivalents of $107.6 million as of Q3 2025, which was up 3382.15% from $320.1 million recorded in Q2 2025.
  • Chemung Financial's Cash & Equivalents' 5-year high stood at $320.1 million during Q2 2025, with a 5-year trough of $2.5 million in Q4 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $56.8 million (2021), whereas its average is $73.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 6339.5% in 2021, then soared by 126067.21% in 2023.
  • Quarter analysis of 5 years shows Chemung Financial's Cash & Equivalents stood at $2.5 million in 2021, then increased by 9.5% to $2.7 million in 2022, then skyrocketed by 1260.67% to $36.8 million in 2023, then increased by 27.65% to $47.0 million in 2024, then soared by 128.86% to $107.6 million in 2025.
  • Its Cash & Equivalents was $107.6 million in Q3 2025, compared to $320.1 million in Q2 2025 and $53.4 million in Q1 2025.